WYE-125132, identified by its CAS number 1144068-46-1, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain protein kinases, which play crucial roles in various cellular processes, including cell growth, differentiation, and metabolism. The compound's structure typically features specific functional groups that contribute to its biological activity and selectivity. In preclinical studies, WYE-125132 has shown promise in inhibiting tumor growth and may be explored for its efficacy in treating certain types of cancer. Its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are essential for determining its suitability for further development as a therapeutic agent. As with many investigational compounds, ongoing research is necessary to fully elucidate its mechanism of action, safety profile, and potential clinical applications.

WYE-125132

1144068-46-1: WYE-125132, identified by its CAS number 1144068-46-1, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain protein kinases, which play crucial roles in various cellular processes, including cell growth, differentiation, and metabolism. The compound's structure typically features specific functional groups that contribute to its biological activity and selectivity. In preclinical studies, WYE-125132 has shown promise in inhibiting tumor growth and may be explored for its efficacy in treating certain types of cancer. Its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are essential for determining its suitability for further development as a therapeutic agent. As with many investigational compounds, ongoing research is necessary to fully elucidate its mechanism of action, safety profile, and potential clinical applications.

Urea, N-[4-[1-(1,4-dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methyl-

WYE-132

<p>mTOR kinase inhibitor; anti-neoplastic</p>

WYE 125132

WYE-125132: potent mTOR inhibitor, IC50 0.19 nM, selective over PI3Ks/hSMG1/ATR.

CAS 1144068-46-1

WYE-125132

Urea, N-[4-[1-(1,4-dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methyl-

Ref: IN-DA000B9J

WYE-132

Ref: 54-BUP09353

WYE 125132

Ref: 3D-FW65208

WYE-132

Ref: TM-T6346